World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: PACTR
Last refreshed on: 29 May 2023
Main ID:  PACTR201711002730365
Date of registration: 30/10/2017
Prospective Registration: No
Primary sponsor: mekki marwa
Public title: Impact of pulmonary rehabilitation programme for chronic obstructive pulmonary disease (COPD) patients
Scientific title: evaluation of the combined effect of endurance training or strength training on endurance tolerance and muscle strength of the lower limbs.
Date of first enrolment: 11/09/2017
Target sample size: 65
Recruitment status: Recruiting
URL:  https://pactr.samrc.ac.za/TrialDisplay.aspx?TrialID=2730
Study type:  Interventional
Study design:  Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomisation using a radomisation table created by a computer software program,Allocation was determined by the holder of the sequence  
Phase:  Not Applicable
Countries of recruitment
Tunisia
Contacts
Name: Marwa    Mekki
Address:  Avenue Mohamed Karoui, 4002, Sousse, Tunisia 4002 sousse Tunisia
Telephone: +21652918384
Email: Mekkimarwa52@yahoo.fr
Affiliation:  Department of Physiology and Lung Function Testing University of Sousse
Name: Yassine    Trabelsi
Address:  Avenue Mohamed Karoui, 4002, Sousse, Tunisia 4002 sousse Tunisia
Telephone: +21620202963
Email: trabelsiyassine@yahoo.fr
Affiliation:  Department of Physiology and Lung Function Testing University of Sousse
Key inclusion & exclusion criteria
Inclusion criteria: (1) Stable COPD patients, absence of other obstructive disease (eg, asthma, bronchiectasis); (3) lack of recent cardiac or neuromuscular pathologies; and (4) a fall in the last 5 years or a recent near-fall. Individuals who smoked and those who had a significant response to bronchodilators, defined as an increase > 12% in forced expiratory volume in 1 second .
Exclusion criteria: cognitive deficiency, a neurological or locomotive condition that may impair their mobility and balance were excluded from the study

Age minimum: 60 Year(s)
Age maximum: 71 Year(s)
Gender: Male
Health Condition(s) or Problem(s) studied

Respiratory
chronic obstructive pulmonary disease
Respiratory
chronic obstructive pulmonary disease
Intervention(s)
ET added to neuromuscular electrical stimulation
ET added to voluntary contraction
Primary Outcome(s)
6-Minutes Walking Test (6MWT), maximal voluntary contraction (MVC), electromyography (EMG)
Secondary Outcome(s)
spirometry
Secondary ID(s)
Source(s) of Monetary Support
Department of Physiology and Lung Function Testing (UR12 ES06), Faculty of Medicine of Sousse, University of Sousse, Tunisia
Secondary Sponsor(s)
Prof. Zouhair tabka
Ethics review
Status: Approved
Approval date: 03/04/2017
Contact:
the Research Ethics Committee of Farhat Hached Hospital (Sousse)
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history